Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCallary, S.-
dc.contributor.authorCampbell, D.-
dc.contributor.authorMercer, G.-
dc.contributor.authorNilsson, K.-
dc.contributor.authorField, J.-
dc.identifier.citationClinical Orthopaedics and Related Research, 2013; 471(7):2238-2244-
dc.description.abstractBACKGROUND One cross-linked polyethylene (XLPE) liner is manufactured using a lower dose of radiation, 5 Mrad, which may result in less cross-linking. The reported in vivo wear rate of this XLPE liner in patients undergoing THA has varied, and has included some patients in each reported cohort who had greater than 0.1 mm/year of wear, which is an historical threshold for osteolysis. Previous studies have measured wear on plain radiographs, an approach that has limited sensitivity. QUESTIONS/PURPOSES We therefore measured the amount and direction of wear at 6 years using Radiostereometric analysis (RSA) in patients who had THAs that included a cross-linked polyethylene liner manufactured using 5 Mrad radiation. METHODS We prospectively reviewed wear in 30 patients who underwent primary THAs with the same design of cross-linked acetabular liner and a 28-mm articulation. Tantalum markers were inserted during surgery and all patients had RSA radiographic examinations at 1 week, 6 months, 1, 2, and 6 years postoperatively. RESULTS The mean proximal, two-dimensional (2-D) and three-dimensional (3-D) wear rates calculated between 1 year and 6 years were 0.014, 0.014, and 0.018 mm/per year, respectively. The direction of the head penetration recorded between 1 week and 6 years was in a proximal direction for all patients, proximolateral for 16 of 24 patients, and proximomedial for eight of 24 patients. CONCLUSIONS The proximal, 2-D and 3-D wear of a XLPE liner produced using 5 Mrad of radiation was low but measurable by RSA after 6 years. No patients had proximal 2-D or 3-D wear rates exceeding 0.1 mm/year. Further followup is needed to evaluate the effect of XLPE wear particles on the development of long-term osteolysis. The institution of one or more of the authors (GM) has received, during the study period, funding from Depuy (Warsaw, IN, USA). All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research editors and board members are on file with the publication and can be viewed on request. Clinical Orthopaedics and Related Research neither advocates nor endorses the use of any treatment, drug, or device. Readers are encouraged to always seek additional information, including FDA-approval status, of any drug or device prior to clinical use. Each author certifies that his institution has approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained. This work was performed at the Repatriation General Hospital, Adelaide, South Australia, Australia.-
dc.description.statementofresponsibilityStuart A. Callary, David G. Campbell, Graham Mercer, Kjell G. Nilsson, John R. Field-
dc.publisherLippincott Williams & Wilkins-
dc.rights© The Association of Bone and Joint Surgeons 2013-
dc.subjectHip Joint-
dc.subjectProsthesis Failure-
dc.subjectTreatment Outcome-
dc.subjectArthroplasty, Replacement, Hip-
dc.subjectProspective Studies-
dc.subjectProsthesis Design-
dc.subjectHip Prosthesis-
dc.subjectStress, Mechanical-
dc.subjectTime Factors-
dc.subjectAged, 80 and over-
dc.subjectMiddle Aged-
dc.subjectFiducial Markers-
dc.subjectRadiostereometric Analysis-
dc.titleWear of a 5 megarad cross-linked polyethylene liner: a 6-year RSA study-
dc.typeJournal article-
dc.identifier.orcidCallary, S. [0000-0002-2892-5238]-
dc.identifier.orcidCampbell, D. [0000-0002-1572-9529]-
Appears in Collections:Aurora harvest 4
Orthopaedics and Trauma publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.